Martin Forster

University College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (10)

Miriam Molina Arcas

The Francis Crick Institute

UNITED KINGDOM

View details

Matthew Krebs

Clinical Senior Lecturer

The University of Manchester

UNITED KINGDOM

View details

Hans Prenen

Antwerp University Hospital

BELGIUM

View details

Richard Neal

University of Exeter

UNITED KINGDOM

View details

Lao Saal

Associate Professor, Head, Translational Oncogenomics Unit

Lund University

SWEDEN

View details

Ruth Plummer

Clinical Professor

Newcastle University

UNITED KINGDOM

View details

Clare Weeden

The Francis Crick Institute

UNITED KINGDOM

View details

Nicolai Birkbak

Aarhus University

DENMARK

View details

Gary Middleton

Professor of Medical Oncology

University of Birmingham

UNITED KINGDOM

View details

Alvina Lai

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Martin Forster

Research Interests

Explore related searches

Contact this professor

Articles (10)

A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer

Cumulative burden of 144 conditions, critical care hospitalisation and premature mortality across 26 adult cancers.

Body composition and lung cancer-associated cachexia in TRACERx

Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

Lung adenocarcinoma promotion by air pollutants

Antibodies against endogenous retroviruses promote lung cancer immunotherapy.

Genomic-transcriptomic evolution in lung cancer and metastasis

Copy number architectures define treatment-mediated selection of lethal prostate cancer clones

Development and validation of a risk score (Delay-7) to predict the occurrence of a treatment delay following cycle 1 chemotherapy

Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: Results from an expanded phase i study

Collaborators (10)

Miriam Molina Arcas

Matthew Krebs

Hans Prenen

Richard Neal

Lao Saal

Ruth Plummer

Clare Weeden

Nicolai Birkbak

Gary Middleton

Alvina Lai

Make your next move.